GENEVA, Sept. 21 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1, Doshomachi 4-chomeChuo-kuOsaka-shi, Osaka 541-8645) filed a patent application (PCT/IB2025/052718) for "CD19 TARGETING CAR NK CELLS IN TREATING SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS" on Mar 14, 2025. With publication no. WO/2025/191531, the details related to the patent application was published on Sep 18, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): SELLNER, Leopold (c/o Takeda Development Center Americas, Inc.95 Hayden AvenueLexington, Massachusetts 02421)
Abstract:
The present disclosure provides, among other...